Gain Therapeutics, Inc.
GANX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819411
No open-market purchases or sales by Gain Therapeutics, Inc. insiders were filed in the last 90 days; 50 institutions reported holding it in 13F filings for Q2 2026, worth $17.4M in total; Greenlight Capital is the only superinvestor holding it.
13F holders, Q4 2024
Institutional positions in Gain Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +6 vs. Q3 2024
- Shares held
- 1.98M
- +308.5K (+18.4%) vs. Q3 2024
- Total value
- $3.94M
- +$1.55M (+64.5%) vs. Q3 2024
- New holders
- 10
- 8 more added
- Sold out
- 4
- 2 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 50 | $17.4M |
| Q1 2026 | 42 | $15.8M |
| Q4 2025 | 48 | $25.9M |
| Q3 2025 | 38 | $7.70M |
| Q2 2025 | 35 | $6.49M |
| Q1 2025 | 33 | $5.07M |
| Q4 2024 | 25 | $3.94M |
| Q3 2024 | 19 | $2.40M |
| Q2 2024 | 28 | $3.89M |
| Q1 2024 | 26 | $7.04M |
| Q4 2023 | 24 | $5.05M |
| Q3 2023 | 24 | $4.95M |
| Q2 2023 | 24 | $5.68M |
| Q1 2023 | 22 | $5.54M |
| Q4 2022 | 21 | $3.78M |
| Q3 2022 | 23 | $3.95M |
| Q2 2022 | 16 | $3.87M |
| Q1 2022 | 16 | $4.75M |
| Q4 2021 | 19 | $5.71M |
| Q3 2021 | 14 | $6.65M |
| Q2 2021 | 14 | $8.95M |
| Q1 2021 | 12 | $15.0M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Gain Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DME Capital Management, LPSuperinvestorGreenlight Capital | 566,130 | $1.22M | 0.06% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 267,421 | $577.7K | 0.00% | −4,551−1.7% | Reduced |
| Vanguard Group Inc | 177,075 | $382.5K | 0.00% | +31,858+21.9% | Added |
| Jones Financial Companies LLLP | 98,250 | $212.2K | 0.00% | +44,750+83.6% | Added |
| Marshall Wace, LLP | 91,738 | $198.2K | 0.00% | +91,738 | New |
| Morgan Stanley | 88,512 | $191.2K | 0.00% | +83,712+1,744.0% | Added |
| BlackRock, Inc. | 86,061 | $185.9K | 0.00% | +1,137+1.3% | Added |
| Northern Trust Corp | 84,586 | $182.7K | 0.00% | +39,642+88.2% | Added |
| State Street Corp | 71,137 | $153.7K | 0.00% | +36,700+106.6% | Added |
| Cambridge Investment Research Advisors, Inc. | 54,500 | $118.0K | 0.00% | +54,500 | New |
| Susquehanna International Group, LLP | 46,913 | $101.3K | 0.00% | +46,913 | New |
| Prelude Capital Management, LLC | 35,820 | $77.4K | 0.01% | 00.0% | Unchanged |
| UBS Group AG | 35,227 | $76.1K | 0.00% | +26,772+316.6% | Added |
| Bridgeway Capital Management, LLC | 30,004 | $64.8K | 0.00% | +30,004 | New |
| Royal Bank of Canada | 17,500 | $38.0K | 0.00% | +17,500 | New |
| Benedict Financial Advisors Inc | 16,000 | $34.6K | 0.01% | +16,000 | New |
| Sandhill Capital Partners LLC | 15,400 | $33.3K | 0.00% | 00.0% | Unchanged |
| Sprott Inc. | 14,000 | $30.2K | 0.00% | +14,000 | New |
| Citadel Advisors LLC | 11,612 | $25.1K | 0.00% | +11,612 | New |
| Creekmur Asset Management LLC | 4,440 | $9.59K | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 4,410 | $9.53K | 0.00% | +4,410 | New |
| Bank of America Corp | 4,085 | $8.82K | 0.00% | +501+14.0% | Added |
| Wells Fargo & Company | 2,650 | $5.72K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 2,000 | $4.32K | 0.00% | +2,000 | New |
| Gotham Asset Management, LLC | 158,155 | – | – | −176,437−52.7% | Reduced |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −53,264−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −4,842−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −4,801−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1,401−100.0% | Sold out |